Researchers have identified that cancer immunotherapy can lead to colitis due to the activation of the immune system. Certain immunotherapies, such as immune checkpoint inhibitors, boost the immune response against cancer cells but may also inadvertently target healthy cells, including those in the colon. This immune system activation can cause inflammation in the colon, resulting in colitis. Understanding the underlying mechanisms is crucial for improving the safety and efficacy of cancer immunotherapy and managing potential side effects like colitis.
Related Posts
Scientists Develop New Tool to Unravel the Mysteries of RNA Modifications
A new tool called iMVP has been developed for the visualization and interpretation of epitranscriptomic data. iMVP uses a nonlinear dimension reduction technique and density-based partition to subtype, visualize, and denoise epitranscriptomic signals. iMVP has been shown to be effective in identifying previously unknown RNA modification motifs and writers, discovering false positives that are undetectable […]
Quantum Biological Tunneling: A New Hope for Cancer Treatment
Quantum biological tunneling is a phenomenon where particles can cross barriers that would normally be impassable. This phenomenon plays a role in many essential life functions, such as cellular respiration and homeostasis. Scientists are now exploring the potential of quantum biological tunneling to develop new cancer treatments. One promising approach is to use bio nanoantennae, […]
Why does Devil’s ivy in the Office make us more productive
Devil’s Ivy stands out as an excellent hanging plant, boasting large green leaves and trailing vines. Not only are they visually appealing, but they also excel at purifying the air by effectively removing toxins. While Devil’s Ivy is known for its low maintenance, occasional pruning is necessary to manage its growth.